Takeda Pharmaceutical Co Ltd (TSE:4502)
円 5,540 +115 (+2.12%) Market Cap: 8.85 Tn Enterprise Value: 13.26 Tn PE Ratio: 0 PB Ratio: 1.16 GF Score: 66/100

Q3 2023 Takeda Pharmaceutical Co Ltd Earnings Presentation Transcript

Feb 02, 2023 / 10:30AM GMT
Release Date Price: 円4054 (-0.52%)

Feb 02, 2023 / 10:30AM GMT
Presentation
Feb 02, 2023 / 10:30AM GMT

=====================
Corporate Participants
=====================
* Andrew S. Plump
Takeda Pharmaceutical Company Limited - President of Research & Development and Representative Director
* Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
* Christopher David O'Reilly
Takeda Pharmaceutical Company Limited - Global Head of IR & Global Finance
* Constantine Saroukos
Takeda Pharmaceutical Company Limited - CFO & Representative Director

=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Motoya Kohtani
Nomura Securities Co. Ltd., Research Division - Senior Analyst
* Seiji Wakao
JPMorgan Chase & Co, Research Division - VP
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

=====================
Christopher David O'

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot